The Committee on Pediatric and Adolescent HIV (COPAH) provides guidelines and recommendations for the care and treatment of infants, children and adolescents with HIV and their families through the development of AAP policy statements. Through this work, COPAH aims to reduce risk, promote testing, expand education and prevention, advance equitable access to care, reduce stigma, optimize treatment options, and improve the health outcomes and quality of life for infants, children and adolescents living with and at risk for HIV.


The AAP has been at the forefront of research in pediatric HIV infection since the beginning of the HIV epidemic. In response to the increasing numbers of children with HIV infection in the United States, the AAP developed a Task Force on Pediatric AIDS in 1987, which became the Provisional Committee on Pediatric AIDS in 1992, and the Committee on Pediatric AIDS in 1995. In 2022 the Committee requested a name change to the Committee on Pediatric and Adolescent HIV.

View policy statements

Committee Members

Natella Yurievna Rakhmanina MD, PhD FAAP


Rockville, MD

Lisa Lynn Abuogi MD FAAP

Committee Member

Denver, CO

Susan L. Gillespie MD PhD FAAP

Committee Member

Houston, TX

Jennifer Jao MD, MPH FAAP

Committee Member

Chicago, IL

Anne Neilan MD, MPH FAAP

Committee Member

Auburndale, MA

Rosemary Marie Olivero MD FAAP

Committee Member

Ada, MI

Julia Catherine Rosebush DO FAAP

Committee Member

Chicago, IL

George Kelly Siberry MD, MPH FAAP

Section Member, Section on Global Health (SOGH)

New York, NY

Franklin Yates MD, MA

Liaison; National Institute for Child Health and Human Development

Bethesda, MD

Athena P. Kourtis MD, PhD, MPH

Consultant; Committee on Infectious Diseases (COID)

Atlanta, GA

Heather Stob

Manager, Committee on Pediatric & Adolescent HIV

Itasca, IL

Madeline Curtis JD

Director, Federal Advocacy

Washington, DC

Omonigho Ufomata

Director, State Advocacy

Itasca, IL

Last Updated



American Academy of Pediatrics